Nova Pharma Solutions Berhad announced unaudited consolidated earnings results for the six months and year-to-date ended December 31, 2017. For the six months, the company's revenue was MYR 3,669,000 against MYR 4,056,000 a year ago. Profit from operating activities was MYR 1,454,000 against MYR 2,176,000 a year ago. Profit before tax was MYR 1,454,000 against MYR 2,176,000 a year ago. Profit and total comprehensive income attributable to owners of the company was MYR 1,450,000 or MYR 0.21 per basic share against MYR 2,172,000 or MYR 2.17 per basic share a year ago. For the year-to-date, the company's revenue was MYR 7,133,000 against MYR 7,372,000 a year ago. Profit from operating activities was MYR 2,659,000 against MYR 2,826,000 a year ago. Profit before tax was MYR 2,659,000 against MYR 2,826,000 a year ago. Profit and total comprehensive income attributable to owners of the company was MYR 2,649,000 or MYR 0.39 per basic share against MYR 2,819,000 or MYR 2.82 per basic share a year ago. Cash flows generated from operating activities was MYR 1,790,000 against MYR 2,995,000 a year ago. Purchase of property, plant and equipment was MYR 23,000 against MYR 92,000 a year ago.